List of Atherogenics patents

List of Atherogenics patents

List of Hyalex Orthopaedics patents

List of Mando Corporation patents

List of Molecule Works Inc. patents

Open core venture capital investors

CEOs of travel technology companies

Patents where

Current Assignee

Name

is

Atherogenics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7273948 Process of preparing esters and ethers of probucol and derivatives thereof	Patent 7273948 was granted and assigned to Atherogenics on September, 2007 by the United States Patent and Trademark Office.		Atherogenics		United States Patent and Trademark Office	7273948	September 25, 2007
	‌ US Patent 7183317 Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality	Patent 7183317 was granted and assigned to Atherogenics on February, 2007 by the United States Patent and Trademark Office.		Atherogenics		United States Patent and Trademark Office	7183317	February 27, 2007
	‌ US Patent 7094801 Chalcone derivatives and their use to treat diseases	Patent 7094801 was granted and assigned to Atherogenics on August, 2006 by the United States Patent and Trademark Office.		Atherogenics		United States Patent and Trademark Office	7094801	August 22, 2006
	‌ US Patent 7087645 Compounds and methods for treating transplant rejection	Patent 7087645 was granted and assigned to Atherogenics on August, 2006 by the United States Patent and Trademark Office.		Atherogenics		United States Patent and Trademark Office	7087645	August 8, 2006
	‌ US Patent 7294737 Process of preparing esters and ethers of probucol and derivatives thereof	Patent 7294737 was granted and assigned to Atherogenics on November, 2007 by the United States Patent and Trademark Office.		Atherogenics		United States Patent and Trademark Office	7294737	November 13, 2007
	‌ US Patent 7371895 Salt forms of poorly soluble probucol esters and ethers	Patent 7371895 was granted and assigned to Atherogenics on May, 2008 by the United States Patent and Trademark Office.		Atherogenics		United States Patent and Trademark Office	7371895	May 13, 2008
	‌ US Patent 7247714 Protection against oxidative stress and inflammation by a cytoprotective response element	Patent 7247714 was granted and assigned to Atherogenics on July, 2007 by the United States Patent and Trademark Office.		Atherogenics		United States Patent and Trademark Office	7247714	July 24, 2007
	‌ US Patent 7202247 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders	Patent 7202247 was granted and assigned to Atherogenics on April, 2007 by the United States Patent and Trademark Office.		Atherogenics		United States Patent and Trademark Office	7202247	April 10, 2007
	‌ US Patent 7375252 Compounds and method for the inhibition of the expression of VCAM-1	Patent 7375252 was granted and assigned to Atherogenics on May, 2008 by the United States Patent and Trademark Office.		Atherogenics		United States Patent and Trademark Office	7375252	May 20, 2008
	‌ US Patent 7078431 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders	Patent 7078431 was granted and assigned to Atherogenics on July, 2006 by the United States Patent and Trademark Office.		Atherogenics		United States Patent and Trademark Office	7078431	July 18, 2006
	‌ US Patent 6960683 Salt forms of poorly soluble probucol esters and ethers	Patent 6960683 was granted and assigned to Atherogenics on November, 2005 by the United States Patent and Trademark Office.		Atherogenics		United States Patent and Trademark Office	6960683	November 1, 2005
	‌ US Patent 7071158 Antioxidant enhancement of therapy for hyperproliferative conditions	Patent 7071158 was granted and assigned to Atherogenics on July, 2006 by the United States Patent and Trademark Office.		Atherogenics		United States Patent and Trademark Office	7071158	July 4, 2006
	‌ US Patent 6852878 Thioketals and thioethers for inhibiting the expression of VCAM-1	Patent 6852878 was granted and assigned to Atherogenics on February, 2005 by the United States Patent and Trademark Office.		Atherogenics		United States Patent and Trademark Office	6852878	February 8, 2005
	‌ US Patent 6881860 Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality	Patent 6881860 was granted and assigned to Atherogenics on April, 2005 by the United States Patent and Trademark Office.		Atherogenics		United States Patent and Trademark Office	6881860	April 19, 2005
	‌ US Patent 6887712 Methods and compositions to lower plasma cholesterol levels	Patent 6887712 was granted and assigned to Atherogenics on May, 2005 by the United States Patent and Trademark Office.		Atherogenics		United States Patent and Trademark Office	6887712	May 3, 2005

15 results

0 selected

15 results

0 selected